The Bharat Biotech CEO, Dr Krishna Ella, today hit out at his detractors questioning the clearance received by the Covaxin drug despite no efficacy data being submitted. In a hard-hitting press conference, Dr Ella said it was unfair that an Indian company was being targeted.
